All Phenotypes Inpp5d<tm1Rav> MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Cd79a^tm1(cre)Reth/Cd79a⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav	involves: 129 * BALB/c * C57BL/6	MGI:6376530
cn2	Inpp5d^tm1Rav/Inpp5d^tm1Rav Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghAb36-65)1Wys/0	involves: 129 * BALB/c * C57BL/6 * FVB/N	MGI:6376533
cn3	Cd19^tm1(cre)Cgn/Cd19⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav Pten^tm1Hwu/Pten^tm1Hwu	involves: 129P2/OlaHsd * 129S4/SvJae	MGI:5013951
cn4	Inpp5d^tm1Rav/Inpp5d^tm1.1Rav Lyz2^tm1(cre)Ifo/Lyz2⁺	involves: 129P2/OlaHsd * C57BL/6	MGI:3716739
cn5	Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/?	involves: C57BL/6 * DBA/2	MGI:3716749

Allelic Composition	Cd79a^tm1(cre)Reth/Cd79a⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav
Genetic Background	involves: 129 * BALB/c * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd79a^tm1(cre)Reth mutation (3 available); any Cd79a mutation (24 available)
Inpp5d^tm1Rav mutation (1 available); any Inpp5d mutation (94 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:178833 )

• mice have a less than 40% survival rate at 1 year

immune system

increased IgG level ( J:178833 )

• IgG deposition in kidney glomeruli is seen at 20 weeks of age

increased susceptibility to systemic lupus erythematosus ( J:178833 )

• mice show autoantibodies that are specifically seen in lupus; ssDNA, dsDNA, dsRNA and chromatin

increased autoantibody level ( J:178833 )

increased anti-nuclear antigen antibody level ( J:178833 )

• anti-nuclear antibodies in the sera in 20-week old mice

increased anti-chromatin antibody level ( J:178833 )

• mice exhibit chromatin autoantibodies at 8 weeks of age and at 20 weeks of age, mice show chromatin antibodies at amounts comparable to those seen in NZB/NZW mice

increased anti-double stranded DNA antibody level ( J:178833 )

increased anti-single stranded DNA antibody level ( J:178833 )

hematopoietic system

increased IgG level ( J:178833 )

• IgG deposition in kidney glomeruli is seen at 20 weeks of age

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
systemic lupus erythematosus		DOID:9074	OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420	J:178833

Allelic Composition	Inpp5d^tm1Rav/Inpp5d^tm1Rav Cd79a^tm1(cre)Reth/Cd79a⁺ Tg(IghAb36-65)1Wys/0
Genetic Background	involves: 129 * BALB/c * C57BL/6 * FVB/N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal B cell negative selection ( J:178833 )

• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection

increased plasma cell number ( J:178833 )

• increase in frequency of plasma cells in the B cell population (4.96% of B cells compared to 0.04% in controls)

decreased B cell number ( J:178833 )

• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection

abnormal B cell anergy ( J:178833 )

• cell surface mIgM and mIgD are reduced 50% in B cells and B cells express reduced CD93, CD95, and CD80 indicating a loss of anergic B cells

• B cells lose features of anergy, including antigen unresponsiveness measured by BCR aggregation-induced Akt activation and calcium mobilization

• increase in frequency of B cells with activated phenotype (CD86+)

increased autoantibody level ( J:178833 )

• mice spontaneously express about 4-fold increased autoantibody by 20 weeks of age

hematopoietic system

abnormal B cell negative selection ( J:178833 )

• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection

increased plasma cell number ( J:178833 )

• increase in frequency of plasma cells in the B cell population (4.96% of B cells compared to 0.04% in controls)

decreased B cell number ( J:178833 )

• peripheral B cell numbers are reduced by about 70%, suggesting enhanced negative selection

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

lethargy ( J:166155 )

• mutants exhibit lethargy by 4 months of age

hunched posture ( J:166155 )

• mutants exhibit a hunched posture by 4 months of age

growth/size/body

weight loss ( J:166155 )

• mutants exhibit weight loss by 4 months of age

enlarged spleen ( J:166155 )

• mutants exhibit splenomegaly by 4 months of age

hematopoietic system

enlarged spleen ( J:166155 )

• mutants exhibit splenomegaly by 4 months of age

abnormal B cell morphology ( J:166155 )

• CD19+ B cells are larger than B cells from wild-type mice

• B cell neoplasia

decreased B cell number ( J:166155 )

• reduction in the frequency of B cells in asymptomatic double mutant mice as compared to controls or either single mutant mouse

increased B cell number ( J:166155 )

• mutants older than 6 months of age have a 3-fold increase in the percentage of recirculating B cells in the blood, concurrent with onset of disease

abnormal myeloid leukocyte morphology ( J:166155 )

• tissues containing the expanded B cell population also display an expansion of CD11b+ myeloid cells

increased spleen white pulp amount ( J:166155 )

• spleens of mutants over 6 months of age exhibit an expansion of CD19+ B cells, resulting in enlarged white pulp areas that often infiltrate and compress the red pulp

abnormal B cell physiology ( J:166155 )

• B cells exhibit enhanced survival

increased B cell proliferation ( J:166155 )

• B cells proliferate to the prosurvival factor B cell activating factor (BAFF) while wild-type B cells do not

• B cells show a more robust proliferative response to LPS or anti-CD40 than wild-type mice

immune system

enlarged spleen ( J:166155 )

• mutants exhibit splenomegaly by 4 months of age

abnormal B cell morphology ( J:166155 )

• CD19+ B cells are larger than B cells from wild-type mice

• B cell neoplasia

decreased B cell number ( J:166155 )

• reduction in the frequency of B cells in asymptomatic double mutant mice as compared to controls or either single mutant mouse

increased B cell number ( J:166155 )

• mutants older than 6 months of age have a 3-fold increase in the percentage of recirculating B cells in the blood, concurrent with onset of disease

abnormal myeloid leukocyte morphology ( J:166155 )

• tissues containing the expanded B cell population also display an expansion of CD11b+ myeloid cells

increased spleen white pulp amount ( J:166155 )

• spleens of mutants over 6 months of age exhibit an expansion of CD19+ B cells, resulting in enlarged white pulp areas that often infiltrate and compress the red pulp

abnormal B cell physiology ( J:166155 )

• B cells exhibit enhanced survival

increased B cell proliferation ( J:166155 )

• B cells proliferate to the prosurvival factor B cell activating factor (BAFF) while wild-type B cells do not

• B cells show a more robust proliferative response to LPS or anti-CD40 than wild-type mice

integument

abnormal coat appearance ( J:166155 )

• mutants exhibit ruffled fur by 4 months of age

mortality/aging

premature death ( J:166155 )

• severe morbidity and death occurs in all mutants by 1 year of age

neoplasm

increased lymphoma incidence ( J:166155 )

• mutants develop marginal zone lymphoma, and less frequently, follicular B cell lymphoma or centroblastic lymphoma

increased follicular lymphoma incidence ( J:166155 )

increased splenic marginal zone lymphoma incidence ( J:166155 )

• mutants develop spontaneous and lethal mature B cell neoplasms consistent with marginal zone lymphoma

increased malignant tumor incidence ( J:166155 )

• lymphoma infiltrates are seen in nonlymphoid tissues, including liver, lung, heart, and kidney

increased plasmacytoma incidence ( J:166155 )

cellular

increased B cell proliferation ( J:166155 )

• B cells proliferate to the prosurvival factor B cell activating factor (BAFF) while wild-type B cells do not

• B cells show a more robust proliferative response to LPS or anti-CD40 than wild-type mice

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
B-cell lymphoma		DOID:707		J:166155

Allelic Composition	Inpp5d^tm1Rav/Inpp5d^tm1.1Rav Lyz2^tm1(cre)Ifo/Lyz2⁺
Genetic Background	involves: 129P2/OlaHsd * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Inpp5d^tm1.1Rav mutation (0 available); any Inpp5d mutation (94 available)
Inpp5d^tm1Rav mutation (1 available); any Inpp5d mutation (94 available)
Lyz2^tm1(cre)Ifo mutation (14 available); any Lyz2 mutation (40 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

enlarged spleen ( J:119256 )

• splenomegaly develops at about 5 weeks of age

absent marginal zone B cells ( J:119256 )

• marginal zone B cells are depleted

abnormal spleen marginal zone macrophage morphology ( J:119256 )

• marginal zone macrophages are reorganized

immune system

enlarged spleen ( J:119256 )

• splenomegaly develops at about 5 weeks of age

absent marginal zone B cells ( J:119256 )

• marginal zone B cells are depleted

abnormal spleen marginal zone macrophage morphology ( J:119256 )

• marginal zone macrophages are reorganized

growth/size/body

enlarged spleen ( J:119256 )

• splenomegaly develops at about 5 weeks of age

Allelic Composition	Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/?
Genetic Background	involves: C57BL/6 * DBA/2

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Inpp5d^tm1Rav mutation (1 available); any Inpp5d mutation (94 available)
Tg(Cd4-cre)1Cwi mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

immune system

abnormal cytotoxic T cell physiology ( J:122796 )

• APC/OVA primed peripheral CD8+ cells have significantly enhanced cytolitic efficiency

abnormal interferon level ( J:122796 )

• under nonpolarizing conditions, IFNgamma levels are higher

abnormal lymph node germinal center morphology ( J:122796 )

• following infection with Alu/NP-CGG, B cell germinal centers are reduced 3-fold

abnormal humoral immune response ( J:122796 )

• following infection with Alu/NP-CGG, Th2 cytokine levels are reduced

abnormal interleukin secretion ( J:122796 )

• following infection with Alu/NP-CGG, lower levels of IL-4, IL-5, and IL-13 are produced

• under nonpolarizing conditions, markedly lower levels of IL-4, IL-5, and IL-13 are produced

decreased susceptibility to parasitic infection ( J:122796 )

• following infection with S. mansoni, mice have smaller granulomas and somewhat reduced levels of eosinophils in the lung and significantly reduced levels of IL-13 Ralpha2 in serum

• in vitro exposure of lymph nodes with ConA or Schistosome egg antigen results in a reduced production of IL4 and IL5 and reduced proliferation of T cells

homeostasis/metabolism

abnormal interferon level ( J:122796 )

• under nonpolarizing conditions, IFNgamma levels are higher

hematopoietic system

abnormal cytotoxic T cell physiology ( J:122796 )

• APC/OVA primed peripheral CD8+ cells have significantly enhanced cytolitic efficiency

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24